subgroups. For most clinical scenarios (PICO questions) there were few or no head-to-head comparison studies identified in the literature review. Thus, the quality of evidence was most often low or very low, and only occasionally moderate (Supplementary Appendix 5; http://onlinelibrary.wiley.com/ doi/10.1002/art.40726/abstract The 2018 ACR/NPF guideline for the treatment of PsA will assist patients and their health care providers in making challenging disease management decisions. More